Drugs
Are near-death experiences just psychedelic trips?
One possible explanation of near death experiences is that our brains are flooded with a hallucinogenic, DMT.
Meth addiction treatments are finally on the horizon
New antibody and drug therapies may soon help treat meth patients, who currently have no pharmacological interventions.
San Francisco decriminalizes plant-based psychedelics
San Francisco joins Oakland, Santa Cruz, DC, and Denver in decriminalizing some psychedelics.
Microdosing’s benefits may be powered by belief
A small, double-blind, placebo-controlled study has found evidence that expectations may be behind microdosing’s beneficial effects.
The Biden administration is preparing for legal psychedelics within two years
The Biden administration’s Department of Health and Human Services has sent a memo supportive of psychedelic therapies. What does that mean for the field?
Your genes may impact psychedelic experiences
UNC researchers have found evidence that the genetic makeup of a crucial receptor may impact your psychedelic experience.
What your weed label really means
Through the largest analysis of commercial cannabis flower yet, Colorado researchers have found that the current labeling system falls short.
Archaeologists identify contents of ancient Mayan drug containers
Archaeologists used new methods to identify contents of Mayan drug containers, discovering a non-tobacco plant.
The first FDA-approved clinical trial of psilocin has begun
“This has never been done before,” says Filament’s CEO.
Psychedelic research returns to Veterans Affairs
After decades, the Department of Veterans Affairs is once again investigating psychedelic therapies.